Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.63), in-line with the analyst estimate of ($1.63). Revenue for the quarter came in at $8.76 million versus the consensus estimate of $10.6 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.